Andrew Hore – Quoted Micro 12 April 2021
AQUIS STOCK EXCHANGE Virgata Services is making a 50p a share cash offer for Walls & Futures REIT (WAFR) and that is a 52% discount to net assets at the end of September 2020. It is a premium to the market price prior to the announcement, but management recommends shareholders take no action. The bid […]
Andrew Hore – Quoted Micro 6 April 2021
AQUIS STOCK EXCHANGE Good Energy (GOOD) says that customer numbers have remained stable since September. The 2020 figures will be published on 13 April. There was £18.1m in the bank at the end of 2020. Good has restructured its two renewable generation debts into one debt facility of £39.8m. Arbuthnot Banking Group (ARBB) has completed […]
Andrew Hore – Quoted Micro 1 March 2021
AQUIS STOCK EXCHANGE Incanthera (INC) says that it is prioritising discussions with two global cosmetic companies as potential partners for Sol, a sun cream that prevents skin cancer. Incanthera is also assessing the potential for using the technology to develop other products. Sativa Wellness (SWEL) plans to raise C$4m through a placing of units at […]
Andrew Hore – Quoted Micro 15 February 2021
AQUIS STOCK EXCHANGE Oberon Investments Group (OBE) has joined the Access segment following the reversal of the wealth management business into standard list shell Baskerville Capital. Assets under administration are more than £400m. Oberon was formed in 2017 and acquired investment manager MD Barnard. It also has a corporate broking business, and it is joint […]
Andrew Hore – Quoted Micro 8 February 2021
AQUIS STOCK EXCHANGE Clinical IT developer DXS International (DXSP) is encouraged by the initial results from pilots of the ExpertCare system designed to analyse the electronic records of people with hypertension. DXS is awaiting NHS accreditation. World High Life (LIFE) has appointed Tony Calamita as chief executive. He is a founder of Love Hemp, whose […]
Andrew Hore – Quoted Micro 18 January 2021
AQUIS STOCK EXCHANGE British Honey (BHC) generated revenues of £1.5m in the nine months to December 2020 with more sales online. There was £2.4m in the bank. Rutherford Health (RUTH) has agreed to provide cancer treatment to NHS Trusts and clinical commissioning groups in England. The initial agreement is for two years. A subsidiary of […]
Andrew Hore – Quoted Micro 28 December 2020
AQUIS STOCK EXCHANGE TruSpine Technologies (TSP) has delayed the application for FDA approval of its Cervi-LOK spinal device for up to three months. This is due to a lack of testing time because of Covid-19. Computer modelling has enabled the company to make minor modifications, which widens the market for the device. A £250,000 cash […]
Andrew Hore – Quoted Micro 23 November 2020
AQUIS STOCK EXCHANGE Daniel Thwaites (THW) had a strong eleven months in the year to March 2020, but the final month was unsurprisingly poor for the brewer and pubs operator. Full year revenues edged up from £96.9m to £98.1m, while pre-tax profit fell from £4.5m to £3.6m. Net debt was reduced from £69.7m to £65.4m, […]
Andrew Hore – Quoted Micro 26 October 2020
AQUIS STOCK EXCHANGE Truspine Technologies (TSP) says that the latest tests of Cervi-Lok, which is a spinal stabilisation device, have been positive. The tests used a computer-generated model and it showed that Cervi-Lok had a reduction in range of motion that was better than existing screw-based fixation systems. FDA clearance is expected early next year. […]
Andrew Hore – Quoted Micro 14 September 2020
AQUIS STOCK EXCHANGE Investment company S-Ventures is set to join the market on 16 September. The strategy is to make investments in consumer health and organic food businesses in the UK and Europe. The S-Ventures management will use their expertise to help smaller brands grow faster and achieve greater scale. Up to three acquisitions are […]